Gene Therapy and Targeted Toxins for Glioma
2005 · Current Gene Therapy · 113 citations
https://doi.org/10.2174/156652305774964631
K
Kurt M. Kroeger
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
94
Papers
2.6K
Citations
32
h-index
42
i10-index
Kurt M. Kroeger is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Virus-based gene therapy research & Immunotherapy and Immune Responses & RNA Interference and Gene Delivery. The author has an h-index of 32, co-authored 80 publications.
Papers by this author
worksOne-year Expression From High-capacity Adenoviral Vectors in the Brains of Animals With Pre-existing Anti-adenoviral Immunity: Clinical Implications
2007 · Molecular Therapy · 83 citations
https://doi.org/10.1038/sj.mt.6300305
Plasmacytoid Dendritic Cells in the Tumor Microenvironment: Immune Targets for Glioma Therapeutics
2012 · Neoplasia · 62 citations
https://doi.org/10.1593/neo.12794
Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial
2012 · Human Gene Therapy Methods · 24 citations
https://doi.org/10.1089/hgtb.2012.060
HMGB1 Is Released into the Supernatant of GL26, LLc1, GL261, and B16-F10 Tumor Cell Lines in Response to Treatment with Ad-TK (+GCV), Irradiation, or Temozolomide
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pmed.1000010.g009
Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase I Clinical Trial
2012 · Human Gene Therapy Methods · 0 citations
https://doi.org/10.1089/hum.2012.060
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat